Clindamycin Phosphate

규격

24729-96-2CAS 번호

246-433-0EC 번호

[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphateIUPAC 명칭

C18H34ClN2O8PS화학식

505 g/mol분자량

Clindamycin phosphate; 24729-96-2; Cleocin phosphate; Clindets; Cleocin T; Clindagel; Clindesse; Evoclin; Clinda-Derm; Clindamycin 2-phosphate; Dalacin P; CLINDAMYCIN-2-PHOSPHATE; Dalacin T; 7(S)-Chloro-7-deoxylincomycin 2-phosphate; Clinadac; DTXSID1048677; Clindamycin 2-dihydrogen phosphate; U 28508; CLINDAC; XACIATO; U-28,508; CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%; EH6D7113I8; U-28508; NSC-618653; DTXCID1028603; CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER; CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER; VELTIN COMPONENT CLINDAMYCIN PHOSPHATE; CABTREO COMPONENT CLINDAMYCIN PHOSPHATE; IDP-126 COMPONENT CLINDAMYCIN PHOSPHATE; CHEBI:3746; Clindacin; Zindaclin; Clindacin Etz; Clindacin Pac; Clindacin P; Dalacin c phos; NSC618653; ((2R,3R,4S,5R,6R)-6-(2-chloro-1-(((2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl)amino)propyl)-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl) dihydrogen phosphate; clindamycini phosphas; RefChem:54850; Clindamycin Phosphate 1%; Clindamycin Phosphate USP, 1%; Clindamycin Phosphate Gel USP, 1%; Clindamycin Phoaphate Topical USP, 1%; Clindamycin Phosphate Topical USP, 1%; Clindamycin Phoaphate Topical Solution, 1%; Clindamycin Phosphate Topical Solution, 1%; Cleocin Phosphate (0009-6582) (standalone); Clindamycin Phoaphate Topical Solution USP, 1%; Clindamycin Phosphate Topical Solution USP, 1%; CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE; CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER; L-THREO-alpha-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-((((2S,4R)-1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-, 2-(DIHYDROGEN PHOSPHATE); Methyl 7-chloro-6,7,8-trideoxy-6-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-dihydrogen phosphate; Clindamycin (phosphate); C18H34ClN2O8PS; clindamycin phosphate hydrate; (2R,3R,4S,5R,6R)-6-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2H-pyran-3-yl dihydrogen phosphate; [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate; Evoclin (TN); Dalacin-S (TN); [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] dihydrogen phosphate; Clindamycin injection; CAS-24729-96-2; EINECS 246-433-0; CLINDAMYCIN PHOSPHATE HYDRATE [JAN]; Clindamycin dihydrogenphosphat; UNII-EH6D7113I8; MFCD07793328; Clindamycin-2-dihydrogenphosphat; NCGC00163494-01; NCGC00166320-01; clindamycin-phosphate; Clindamycin phosphate [USAN:USP:JAN]; Clindamycin phosphate CRS; SCHEMBL37148; Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-(dihydrogen phosphate); orb1225524; orb1309626; orb3139470; CHEMBL3184512; Clindamycin phosphate (Standard); HY-B1064R; MSK7833; BDBM241975; CLINDAMYCIN (AS PHOSPHATE); GLXC-07737; Clindamycin phosphate (JP18/USP); CLINDAMYCIN PHOSPHATE [JAN]; HY-B1064; CLINDAMYCIN PHOSPHATE [USAN]; Tox21_113055; Tox21_113410; CLINDAMYCIN PHOSPHATE [VANDF]; MSK7833-100M; s2048; CLINDAMYCIN PHOSPHATE [MART.]; AKOS008901431; CLINDAMYCIN PHOSPHATE [USP-RS]; CLINDAMYCIN PHOSPHATE [WHO-DD]; CLINDAMYCIN PHOSPHATE [WHO-IP]; MSK7833-1000M; AM20485; CCG-269736; Clindamycin phosphate system suitability; CS-4620; NSC 618653; NCGC00386379-01; AS-12554; L-threo-alpha-D-galacto-Octapyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-; Methyl (2S-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-L-threo-alpha-D-galacto-octopyranoside, 2-(dihydrogen phosphate); CLINDAMYCIN PHOSPHATE [ORANGE BOOK]; DUAC COMPONENT CLINDAMYCIN PHOSPHATE; CLINDAMYCIN PHOSPHATE [EP MONOGRAPH]; ZIANA COMPONENT CLINDAMYCIN PHOSPHATE; ACANYA COMPONENT CLINDAMYCIN PHOSPHATE; C4533; CLINDAMYCIN PHOSPHATE [USP MONOGRAPH]; CLINDAMYCINI PHOSPHAS [WHO-IP LATIN]; BENZACLIN COMPONENT CLINDAMYCIN PHOSPHATE; CLINDAMYCIN 2-DIHYDROGEN PHOSPHATE [MI]; D01073; SBI-0654100.0001; AB01566857_01; Clindamycin phosphate for system suitability CRS; SR-01000872581; SR-01000872581-1; BRD-K27771035-001-02-5; Clindamycin phosphate Solution in Methanol, 1000ug/mL; Clindamycin phosphate Solution in Methanol, 100ug/mL; Q27106184; CLINDAMYCIN PHOSPHATE SYSTEM SUITABILITY [USP-RS]; (2R,3R,4S,5R,6R)-6-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2H-pyran-3-yldihydrogenphosphate; (2S-trans)-Methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-.alpha.-D-galacto-octopyranoside 2-(dihydrogen phosphate); L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-((((2S,4R)-1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-, 2-(DIHYDROGEN PHOSPHATE); L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-, 2-(DIHYDROGEN PHOSPHATE), (2S-TRANS)-; METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(1-METHYL-TRANS-4-PROPYL-L-2-PYRROLIDINECARBOXAMIDO)-1-THIO-L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE 2-(DIHYDROGEN PHOSPHATE); Methyl 7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-2-O-phosphono-1-thio-L-threo-alpha-D-galacto-octopyranoside동의어